A human inhibitor of tumor necrosis factor alpha.
Open Access
- 1 April 1988
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 167 (4), 1511-1516
- https://doi.org/10.1084/jem.167.4.1511
Abstract
Urine of some febrile patients exhibits a TNF-alpha inhibitory activity (TNF-alpha INH), sensitive to heat and trypsin, with an apparent mol wt of 40-60 X 10(3) and a pI range of 5.5-6.1. As for the Il-1 INH, the TNF INH activity involves a competitive mechanism of action suggesting the existence of a family of negative feedback-regulating molecules interfering with cytokines actions.This publication has 10 references indexed in Scilit:
- A urine inhibitor of interleukin 1 activity that blocks ligand binding.The Journal of Immunology, 1987
- A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha.The Journal of Immunology, 1987
- Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.1987
- Interleukin-1 inhibitorsAnnales de l'Institut Pasteur / Immunologie, 1987
- Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s).Journal of Clinical Investigation, 1986
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985
- Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.The Journal of Immunology, 1985
- Identity of tumour necrosis factor and the macrophage-secreted factor cachectinNature, 1985
- An endotoxin-induced serum factor that causes necrosis of tumors.Proceedings of the National Academy of Sciences, 1975